Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Aurobindo Pharma Limited
AUROPHARMAAurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India. Address: Galaxy, Plot No. 1, Hyderabad, India, 500032
Analytics
Precio Objetivo de WallStreet
79 738.14 INRRelación P/E
26.0687Rentabilidad por dividendo
0.29 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave AUROPHARMA
Análisis de dividendos AUROPHARMA
Aumento del dividendo durante 5 años
167 %Crecimiento continuo
–Ratio de pago medio en 5 años
10 %Tendencia del payout AUROPHARMA
Valoración de la acción AUROPHARMA
Finanzas AUROPHARMA
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |